tldrdailynews.com logo

Novo Nordisk's New Weight-Loss Pill Shows Promising Results

1 min read
Source: STAT
Novo Nordisk's New Weight-Loss Pill Shows Promising Results
Photo: STAT
TL;DR

Novo Nordisk's new amylin-based obesity drug, amycretin, shows significant weight loss in early trials, but similar efficacy across different doses and high side effects raise questions about optimal dosing strategies.

Topics:businesshealth#amylin#drug-dosing#health#novo-nordisk#obesity#weight-loss
Share this article
  1. Full data on Novo Nordisk’s new amylin drug raise dosing questions  STAT
  2. Novo Nordisk's experimental drug results in up to 24% weight loss  Reuters
  3. Weight loss pill set to rival injections after promising studies  The Independent
  4. Novo’s Latest Obesity Drug Shows 24% Weight Loss in Small Trial  Bloomberg
  5. New weight-loss drug is ‘better than Wegovy’ — and comes in a pill  The Times

Want the full story? Read the original reporting

Read on STAT